State of Alaska Department of Revenue’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.5M | Sell |
252,254
-11,176
| -4% | -$642K | 0.14% | 107 |
|
|
2026
Q1 | $16M | Buy |
263,430
+5,025
| +2% | +$293K | 0.17% | 88 |
|
|
2025
Q4 | $13.9M | Sell |
258,405
-59,405
| -19% | -$2.86M | 0.15% | 107 |
|
|
2025
Q3 | $14.3M | Sell |
317,810
-12,427
| -4% | -$580K | 0.15% | 114 |
|
|
2025
Q2 | $15.3M | Sell |
330,237
-8,990
| -3% | -$441K | 0.16% | 106 |
|
|
2025
Q1 | $20.7M | Sell |
339,227
-23,405
| -6% | -$1.36M | 0.23% | 67 |
|
|
2024
Q4 | $20.5M | Sell |
362,632
-100,365
| -22% | -$5.61M | 0.23% | 65 |
|
|
2024
Q3 | $24M | Sell |
462,997
-91,705
| -17% | -$4.3M | 0.25% | 61 |
|
|
2024
Q2 | $23M | Buy |
554,702
+52,480
| +10% | +$2.35M | 0.26% | 61 |
|
|
2024
Q1 | $27.2M | Sell |
502,222
-47,130
| -9% | -$2.4M | 0.31% | 47 |
|
|
2023
Q4 | $28.2M | Sell |
549,352
-24,110
| -4% | -$1.27M | 0.34% | 40 |
|
|
2023
Q3 | $33.3M | Sell |
573,462
-9,730
| -2% | -$596K | 0.42% | 32 |
|
|
2023
Q2 | $37.3M | Buy |
583,192
+13,580
| +2% | +$911K | 0.44% | 30 |
|
|
2023
Q1 | $39.5M | Sell |
569,612
-3,760
| -0.7% | -$265K | 0.47% | 29 |
|
|
2022
Q4 | $41.3M | Buy |
573,372
+28,029
| +5% | +$2.11M | 0.51% | 26 |
|
|
2022
Q3 | $38.8M | Sell |
545,343
-31,777
| -6% | -$2.31M | 0.52% | 27 |
|
|
2022
Q2 | $44.4M | Buy |
577,120
+56,249
| +11% | +$4.28M | 0.54% | 26 |
|
|
2022
Q1 | $38M | Buy |
520,871
+64,844
| +14% | +$4.35M | 0.4% | 44 |
|
|
2021
Q4 | $28.4M | Sell |
456,027
-40,480
| -8% | -$2.37M | 0.27% | 67 |
|
|
2021
Q3 | $29.4M | Sell |
496,507
-9,767
| -2% | -$643K | 0.3% | 59 |
|
|
2021
Q2 | $33.8M | Sell |
506,274
-86,580
| -15% | -$5.65M | 0.34% | 52 |
|
|
2021
Q1 | $37.4M | Sell |
592,854
-37,350
| -6% | -$2.32M | 0.41% | 40 |
|
|
2020
Q4 | $39.1M | Sell |
630,204
-13,907
| -2% | -$855K | 0.44% | 32 |
|
|
2020
Q3 | $38.8M | Buy |
644,111
+53,799
| +9% | +$3.24M | 0.48% | 32 |
|
|
2020
Q2 | $34.7M | Buy |
590,312
+133,185
| +29% | +$7.97M | 0.44% | 35 |
|
|
2020
Q1 | $25.5M | Buy |
457,127
+23,194
| +5% | +$1.42M | 0.4% | 43 |
|
|
2019
Q4 | $27.9M | Buy |
433,933
+90,843
| +26% | +$5.2M | 0.36% | 45 |
|
|
2019
Q3 | $17.4M | Sell |
343,090
-117,295
| -25% | -$5.51M | 0.24% | 83 |
|
|
2019
Q2 | $20.9M | Buy |
460,385
+21,117
| +5% | +$984K | 0.35% | 56 |
|
|
2019
Q1 | $21M | Buy |
439,268
+196,378
| +81% | +$9.78M | 0.37% | 49 |
|
|
2018
Q4 | $12.6M | Buy |
242,890
+3,885
| +2% | +$209K | 0.24% | 97 |
|
|
2018
Q3 | $14.8M | Buy |
239,005
+1,840
| +0.8% | +$109K | 0.25% | 92 |
|
|
2018
Q2 | $13.1M | Buy |
237,165
+47,440
| +25% | +$2.56M | 0.23% | 102 |
|
|
2018
Q1 | $12M | Buy |
189,725
+30,080
| +19% | +$1.94M | 0.25% | 95 |
|
|
2017
Q4 | $9.78M | Buy |
159,645
+147,415
| +1,205% | +$9.22M | 0.23% | 92 |
|
|
2017
Q3 | $778K | Buy |
12,230
+9,810
| +405% | +$573K | 0.04% | 556 |
|
|
2017
Q2 | $134K | Buy |
2,420
+191
| +9% | +$10.4K | 0.01% | 1018 |
|
|
2017
Q1 | $121K | Buy |
2,229
+60
| +3% | +$3.29K | 0.01% | 862 |
|
|
2016
Q4 | $126K | Buy |
2,169
+129
| +6% | +$7.05K | 0.01% | 577 |
|
|
2016
Q3 | $109K | Buy |
+2,040
| New | +$131K | 0.01% | 348 |
|
|
2014
Q1 | – | Sell |
-47,255
| Closed | -$2.51M | – | 206 |
|
|
2013
Q4 | $2.51M | Buy |
47,255
+1,160
| +3% | +$59.1K | 0.58% | 50 |
|
|
2013
Q3 | $2.13M | Hold |
46,095
| – | – | 0.5% | 62 |
|
|
2013
Q2 | $2.06M | Buy |
+46,095
| New | +$2M | 0.54% | 51 |
|
Other funds holding BMY
State of Alaska Department of Revenue's BMY Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, selling an estimated $642K and leaving 252,254 shares worth $14.5M. The position accounts for 0.14% of the portfolio, ranked #107.
State of Alaska Department of Revenue first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. The position peaked at $44.4M in Q2 2022. 1,989 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- State of Alaska Department of Revenue held 252,254 shares of Bristol-Myers Squibb worth $14.5M as of Q2 2026.
- State of Alaska Department of Revenue sold 11,176 Bristol-Myers Squibb shares in Q2 2026, an estimated $642K.
- Bristol-Myers Squibb made up 0.14% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #107 holding.
- State of Alaska Department of Revenue first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
- State of Alaska Department of Revenue's Bristol-Myers Squibb position peaked at $44.4M in Q2 2022.
- 1,989 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.